Drug intelligence / Profile preview

fluprostenol

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Ophthalmic, Intramuscular
01

Overview

Fluprostenol is a synthetic analogue of prostaglandin F2alpha and an organofluorine compound in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. It acts as a potent and highly selective agonist of the Prostaglandin F2-alpha receptor (FP receptor). Fluprostenol has roles as an antiglaucoma drug, antihypertensive agent, female contraceptive drug, and abortifacient. Its primary mechanism involves activation of the FP receptor leading to phospholipase C activation and increased intracellular calcium via Gq protein signaling[1][4][6]. Ophthalmic solutions of its isopropyl ester prodrug (travoprost) are used for reducing intraocular pressure in open-angle glaucoma and ocular hypertension[1][7]. In veterinary medicine (notably in mares), it is used for its luteolytic effect to control estrus timing[5].

Other names
travoprost acid16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α
02

Targets

PTGFR (Prostaglandin F2 alpha receptor)

Beyond the preview

Go deeper on fluprostenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluprostenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call